Literature DB >> 31868055

Randomized, controlled trial testing the effectiveness and safety of 2.5% and 5% benzoyl peroxide for the treatment of pitted keratolysis.

Charussri Leeyaphan1, Pichaya Limphoka1, Rungsima Kiratiwongwan1, Punyawee Ongsri1, Sumanas Bunyaratavej1.   

Abstract

BACKGROUND: The appropriate dosage and duration of topical benzoyl peroxide gel (BP) treatment of pitted keratolysis (PK) is controversial.
OBJECTIVE: To compare the effectiveness and safety of topical 2.5% and 5% BP for the treatment of PK.
MATERIALS AND METHODS: This randomized, controlled trial was conducted at Chumpol Naval Rating School, Chonburi, Thailand. Naval rating cadets with PK were randomly assigned to either a 2.5% or a 5% BP group and were requested to apply the related medication on each sole once daily, for 2 weeks.
RESULTS: All 42 and 47 participants who were treated with 2.5% and 5% BP, respectively, were included in the later analysis. Self-evaluation of the foot odor level using a visual analog scale (VAS) showed significant decreases for both groups (p<.001). The pitted lesions were evaluated by dermatologists and found to have improved in the 2.5% and 5% BP groups (69.0% versus 63.8%, respectively; p=.457). Side effects did not statistically differ between the two groups (p>.05).
CONCLUSIONS: Either 2.5% or 5% BP can be used for the treatment of PK and foot malodor. Due to the similarities in their efficacies and side effects, the use of 2.5% BP may be preferable.

Entities:  

Keywords:  Pitted keratolysis; benzoyl peroxide; foot odor

Mesh:

Substances:

Year:  2020        PMID: 31868055     DOI: 10.1080/09546634.2019.1708244

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  1 in total

1.  The Correlations between Clinical Features, Dermoscopic and Histopathological Findings, and Treatment Outcomes of Patients with Pitted Keratolysis.

Authors:  Penvadee Pattanaprichakul; Kanokvalai Kulthanan; Sumanas Bunyaratavej; Sasima Eimpunth; Thanaporn Rungruang; Pattriya Chanyachailert; Punyawee Ongsri; Poramin Patthamalai; Kanyalak Munprom; Charussri Leeyaphan
Journal:  Biomed Res Int       Date:  2021-10-25       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.